Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-099463
Filing Date
2016-05-06
Accepted
2016-05-06 12:01:10
Documents
50
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q v437611_10q.htm 10-Q 269661
2 EXHIBIT 31.1 v437611_ex31-1.htm EX-31.1 9477
3 EXHIBIT 31.2 v437611_ex31-2.htm EX-31.2 9597
4 EXHIBIT 32.1 v437611_ex32-1.htm EX-32.1 5706
  Complete submission text file 0001144204-16-099463.txt   2865608

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ecyt-20160331.xml EX-101.INS 632405
6 XBRL TAXONOMY EXTENSION SCHEMA ecyt-20160331.xsd EX-101.SCH 26332
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ecyt-20160331_cal.xml EX-101.CAL 26489
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ecyt-20160331_def.xml EX-101.DEF 167727
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ecyt-20160331_lab.xml EX-101.LAB 248828
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ecyt-20160331_pre.xml EX-101.PRE 206096
Mailing Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906
Business Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906 7654637175
ENDOCYTE INC (Filer) CIK: 0001235007 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35050 | Film No.: 161626694
SIC: 2834 Pharmaceutical Preparations